
National Research Corporation NRC
$ 26.91
1.09%
National Research Corporation PEG Ratio | NRC
Annual PEG Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.14 | -7.26 | 5.85 | 8.14 | 3.79 | 4.13 | 2.6 | 0.354 | 3.84 | 1.22 | -4.57 | -0.588 | -0.34 | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.14 | -7.26 | 0.771 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Fulgent Genetics
FLGT
|
0.21 | $ 25.83 | -1.22 % | $ 795 M | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 80.78 | -4.31 % | $ 4.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
-0.0176 | $ 1.48 | -4.52 % | $ 4.31 M | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 7.0 | -13.43 % | $ 31 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
4.55 | $ 204.62 | -1.43 % | $ 16 B | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 0.29 | -9.5 % | $ 386 K | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 13.19 | 6.46 % | $ 135 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
-0.00446 | $ 2.37 | 15.05 % | $ 9.44 M | ||
|
Myriad Genetics
MYGN
|
-0.00978 | $ 5.66 | -1.39 % | $ 524 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.000061 | $ 4.78 | -1.24 % | $ 3.76 M | ||
|
QIAGEN N.V.
QGEN
|
3.43 | $ 50.52 | -0.07 % | $ 11 B | ||
|
NeoGenomics
NEO
|
0.0904 | $ 16.97 | -3.58 % | $ 2.17 B | ||
|
OPKO Health
OPK
|
0.000067 | $ 1.71 | 0.58 % | $ 1.28 B | ||
|
Pacific Biosciences of California
PACB
|
-0.0332 | $ 2.22 | -5.93 % | $ 666 M | ||
|
Neogen Corporation
NEOG
|
2.11 | $ 11.67 | -3.44 % | $ 2.54 B | ||
|
Precipio
PRPO
|
-0.238 | $ 23.56 | 6.13 % | $ 37.8 M | ||
|
Personalis
PSNL
|
-1.05 | $ 15.9 | -0.31 % | $ 1.42 B | ||
|
Sotera Health Company
SHC
|
-5.37 | $ 16.25 | -1.16 % | $ 4.61 B | ||
|
Quidel Corporation
QDEL
|
0.0133 | $ 11.56 | -4.43 % | $ 487 M | ||
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
-0.637 | $ 5.88 | 10.08 % | $ 2.11 B | ||
|
Global Cord Blood Corporation
CO
|
0.0777 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.12 | - | 0.12 % | $ 80.1 M | ||
|
Aspira Women's Health
AWH
|
-0.000244 | - | -6.19 % | $ 10.5 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.00301 | - | - | $ 9.42 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Twist Bioscience Corporation
TWST
|
2.59 | $ 132.17 | -2.35 % | $ 7.9 B | ||
|
Organovo Holdings
ONVO
|
-0.00781 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
-10.2 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
0.383 | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
0 | - | -8.98 % | $ 14.8 K | ||
|
Waters Corporation
WAT
|
-4.74 | $ 476.29 | -0.09 % | $ 28.4 B | ||
|
Exagen
XGN
|
1.93 | $ 5.26 | -25.92 % | $ 113 M | ||
|
Celcuity
CELC
|
-0.769 | $ 67.13 | -4.11 % | $ 3.14 B | ||
|
Laboratory Corporation of America Holdings
LH
|
34.8 | $ 370.89 | -0.25 % | $ 30.9 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 101.65 | 0.63 % | $ 6.86 B | ||
|
Accelerate Diagnostics
AXDX
|
-0.00013 | - | -61.36 % | $ 2.46 M | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 664.97 | -1.18 % | $ 19.2 B | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 346.21 | -2.02 % | $ 17.2 B | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 750.2 | -0.69 % | $ 36.1 B | ||
|
Danaher Corporation
DHR
|
210 | $ 236.19 | 0.46 % | $ 168 B | ||
|
Koninklijke Philips N.V.
PHG
|
0.115 | $ 30.39 | -1.32 % | $ 28.8 B | ||
|
RadNet
RDNT
|
-52.5 | $ 77.91 | -0.6 % | $ 5.86 B | ||
|
Senseonics Holdings
SENS
|
-0.0158 | $ 10.05 | 2.55 % | $ 419 M |